| Hans-Günter Meyer-Thompson | Buprenorphin
CHMP Backs Two Drugs for Opioid Abuse
The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of naloxone nasal spray (Nyxoid) for the treatment of opioid overdose and buprenorphine plus naloxone sublingual tablets (Zubsolv) for the treatment of opioid dependence. Both products are made by Mundipharma Corporation Limited. (MedScape, 16.09.2017)